Literature DB >> 10080574

Treatment of Tourette's syndrome with delta-9-tetrahydrocannabinol.

K R Müller-Vahl, U Schneider, H Kolbe, H M Emrich.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10080574

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN： 0002-953X            Impact factor:   18.112


× No keyword cloud information.
  22 in total

1.  Treatment of Gilles de la Tourette Syndrome with Cannabis-Based Medicine: Results from a Retrospective Analysis and Online Survey.

Authors:  Leonie M Milosev; Nikolas Psathakis; Natalia Szejko; Ewgeni Jakubovski; Kirsten R Müller-Vahl
Journal:  Cannabis Cannabinoid Res       Date:  2019-12-09

Review 2.  Cannabinoids in clinical practice.

Authors:  E M Williamson; F J Evans
Journal:  Drugs       Date:  2000-12       Impact factor: 9.546

Review 3.  Tourette syndrome: clinical characteristics and current management strategies.

Authors:  E H Kossoff; H S Singer
Journal:  Paediatr Drugs       Date:  2001       Impact factor: 3.022

Review 4.  The endocannabinoid system as an emerging target of pharmacotherapy.

Authors:  Pál Pacher; Sándor Bátkai; George Kunos
Journal:  Pharmacol Rev       Date:  2006-09       Impact factor: 25.468

Review 5.  Pharmacokinetics and pharmacodynamics of cannabinoids.

Authors:  Franjo Grotenhermen
Journal:  Clin Pharmacokinet       Date:  2003       Impact factor: 6.447

Review 6.  [Therapeutic use of cannabinoids in neurology].

Authors:  P Schwenkreis; M Tegenthoff
Journal:  Schmerz       Date:  2003-10       Impact factor: 1.107

Review 7.  The therapeutic potential of cannabinoids for movement disorders.

Authors:  Benzi Kluger; Piera Triolo; Wallace Jones; Joseph Jankovic
Journal:  Mov Disord       Date:  2015-02-04       Impact factor: 10.338

8.  Psychopharmacology of tic disorders.

Authors:  Myriam Srour; Paul Lespérance; Francois Richer; Sylvain Chouinard
Journal:  J Can Acad Child Adolesc Psychiatry       Date:  2008-08

Review 9.  Cannabinoids and glaucoma.

Authors:  I Tomida; R G Pertwee; A Azuara-Blanco
Journal:  Br J Ophthalmol       Date:  2004-05       Impact factor: 4.638

Review 10.  The pharmacology of Tourette syndrome.

Authors:  Roji Thomas; Andrea E Cavanna
Journal:  J Neural Transm (Vienna)       Date:  2013-01-30       Impact factor: 3.575
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.